
CPPGroup Plc
("
HALF YEAR REPORT FOR THE SIX MONTHS ENDED 30 JUNE 2025
TRANSFORMATION INTO AN INSURTECH BUSINESS
Operational Highlights:
· CPP Turkey sold in June for combined proceeds totalling £6.1 million.
· CPP India sold, after the reporting date, for a total consideration of c.£14.4 million.
· Business now focused solely on scaling the Group's InsurTech platform, Blink.
· New Blink CEO,
· Central restructure to a lower cost platform announced and underway.
· Change Management Programme ("CMP") completed.
Financial Highlights:
The financial results below reflect the separation of discontinued operations (including CPP India and CPP Turkey) from the Group's ongoing core business, or "continuing operations".
Group:
· Revenue from continuing operations of £0.9 million (H1 2024 restated: £1.4 million).
· EBITDA loss from continuing operations of £2.9 million (H1 2024 restated: £3.9 million loss).
· Loss before tax from continuing operations of £3.5 million (H1 2024 restated: £4.5 million).
· Cash balance of £8.1 million3 at 30 June 2025 (H1 2024: £11.6 million; 31 December 2024: £9.7 million).
Blink:
· ARR increased by 83% to £2.3 million (H1 2024: £1.3 million).
· Revenue increased by 61% to £0.8 million (H1 2024: £0.5 million).
· EBITDA loss of £1.2 million (H1 2024: £1.0 million loss).
"The first half of 2025 has been a defining stage in CPP's journey. With the disposal of our remaining legacy assistance businesses and the completion of the Change Management Programme, the Group has largely transformed into the focused InsurTech business that was the objective set three years ago. At the centre of this transformation is Blink, our global parametric technology platform, which continues to scale at pace, and which represents the future of the Group. The legacy
Following this strategic transformation, Blink is well positioned to capture the significant growth opportunities in our two core markets of travel disruption and consumer cyber-security. With strong recurring revenues, a growing pipeline of opportunities, and a new CEO in place, we remain confident in Blink's ability to deliver sustainable growth and shareholder value."
Financial highlights - continuing operations
£ millions |
Six months to 30 June 2025 |
Six months to 30 June 2024 (Restated1) |
Change |
Group |
|
|
|
Revenue |
0.9 |
1.4 |
(35)% |
EBITDA2 |
(2.9) |
(3.9) |
25% |
Operating loss |
(3.5) |
(4.5) |
23% |
Loss before tax |
(3.5) |
(4.5) |
22% |
Loss after tax |
(3.5) |
(4.5) |
22% |
Basic loss per share (pence) |
(38.33) |
(50.79) |
25% |
Cash and cash equivalents3 |
8.1 |
11.6 |
(31)% |
|
|
|
|
Blink |
|
|
|
Revenue |
0.8 |
0.5 |
61% |
EBITDA |
(1.2) |
(1.0) |
(24)% |
1. Restated to reflect
2. EBITDA represents earnings before interest, taxation, depreciation, amortisation, and exceptional items.
3. Includes £6.0 million of cash held in
Enquiries:
Panmure Liberum
(Nominated Adviser and Sole Broker) Tel: +44 (0)20 3100 2000
Alma
About
For more information on CPP visit https://corporate.cppgroup.com/
Chief Executive Officer Statement
Overview & Context
The first half of 2025 has represented a pivotal period for
The disposals of CPP Turkey (June 2025) and CPP India (September 2025), together with the recently announced restructuring of the Group's central operations, constitute the final elements of the Change Management Programme ("CMP") initiated in the spring of 2022. As a result, the Group has now realised the strategic transformation it set out to achieve three years ago, establishing itself as a focused InsurTech business operating across two substantial global markets, travel disruption and consumer cyber-security, each of which presents significant long-term growth potential.
First Half Performance: Blink
With the disposal of CPP Turkey in June and with CPP India "Held for Sale" at the reporting date, the commentary which follows is focused on Blink, the Group's sole trading entity within continuing operations.
Our strategic priority is to scale Blink by partnering with major global and regional insurance companies across multiple geographies and product verticals. Progress has been encouraging; Blink now provides travel disruption solutions to 29 partners across 23 geographies.
For the six-month period, Blink increased revenues by 61% to £0.8 million (H1 2024: £0.5 million) and reported an EBITDA loss of £1.2 million (H1 2024: £1.0 million loss).
Blink Key Highlights
|
30 June 2025 |
30 June 2024 |
Change |
Key Performance Indicators |
|
|
|
Annual Recuring Revenues (£'m) |
2.3 |
1.3 |
83% |
Number of Partners |
29 |
24 |
21% |
Number of Markets |
23 |
13 |
77% |
Policies with Blink technology embedded (millions) |
1.8 |
1.1 |
56% |
|
|
|
|
Key Financials (£'m) |
|
|
|
Revenues |
0.8 |
0.5 |
61% |
Gross Profit |
0.7 |
0.4 |
69% |
Gross Profit Margin (%) |
86.6% |
82.5% |
4ppt |
Overheads |
(1.9) |
(1.4) |
(37)% |
EBITDA loss |
(1.2) |
(1.0) |
(24)% |
|
|
|
|
Annual Recurring Revenues
Growth in annual recurring revenues ("ARR") has been driven by strong organic momentum including the signing of a new three-year licensing agreement with Mehrwerk GmbH ("Mehrwerk") to distribute Blink's cyber-security solution across pre-agreed markets. The pipeline of new business opportunities remains robust, and we expect continued progress in the second half of 2025 and beyond. As detailed in our shareholder circular on 29 July 2025, Blink is forecast to increase its ARR to at least £3.0 million by 31 December 2025 and for ARR to continue to grow strongly in 2026 to at least £5.0 million by 31 December 2026.
Alongside ARR growth, contract renewal rates are an important performance indicator for a business such as Blink. High renewal rates highlight the proven utility of Blink's solutions for both business partners and end consumers. Our embedded offering delivers measurable benefits (new customer acquisition, high retention, and improved margins) for our partners, resulting in upper-quartile renewal rates for Blink.
Number of Partners
Sustained growth will depend on securing new business in addition to maintaining high levels of renewals. Given the scale and complexity of the partners we are targeting, conversion requires time, persistence, and rigorous execution. During the six-month period we have added two new partners and moved several further through our pipeline, the benefit of which is expected in H2.
Key Financials
Blink is an operationally geared business with a relatively high level of fixed costs relative to current reported revenues. Over time, as ARR and revenues continue to grow, we expect a far greater proportion of incremental revenues to translate into profit, enhancing operational leverage and driving margin expansion.
First Half Performance: Other Divisions
CPP Turkey and CPP India
The results of both CPP Turkey, which was sold on 17 June 2025, and CPP India, which was held for sale on the reporting date and subsequently sold on 17 September 2025, have been recognised as discontinued operations and do not consequently form part of the Group's continuing operations.
Legacy Business
The legacy business which is in run-off was EBITDA breakeven (H1 2024: £0.5 million loss). However, the
Central Overheads
Overheads have reduced by £0.7 million (30%) to £1.7 million (H1 2024: £2.4 million) reflecting the benefit of the completion of the CMP and a focus on cost reduction.
Taxation
Following the transfer of CPP India and CPP Turkey to discontinued operations, the Group's tax charge from continuing operations is £nil (H1 2024 restated: £nil). The Group's continuing operations currently consists of solely loss-making businesses, which carry substantial available tax losses; therefore, the Group does not expect to incur a tax charge in the medium- to long-term.
Cash Flow
The Group had cash balances at 30 June 2025 of £8.1 million (H1 2024: £11.6 million; 31 December 2024: £9.7 million) which included £6.0 million cash balances in
As part of the disposal of CPP Turkey, the Group agreed to reduce its revolving credit facility ("RCF") by 50% to £2.5 million. The RCF has subsequently been repaid and withdrawn following the disposal of CPP India in September, there was £1.5 million drawn on the RCF prior to cancellation. The Group's immediate funding requirements, including growth investment in Blink, will be satisfied by cash proceeds from the sale of CPP India and CPP Turkey. Continued commercial progress in Blink and the full cost benefits of central restructuring will improve operational cash flows.
Balance Sheet
At 30 June 2025, the Group had net assets of £0.4 million which was an increase of £0.4 million from the 31 December 2024 net liabilities position of £0.0 million. The disposal of CPP India, which completed on 17 September 2025 represents a material subsequent event and has changed the shape of the Group's balance sheet significantly. In isolation, the transaction will improve the Group's existing net assets position by approximately £9.6 million, as detailed in the pro forma statement of consolidated assets below. Further detail on the transaction is included in note 12 to the condensed consolidated financial statements.
The unaudited pro forma statement of consolidated assets below has been produced for illustrative purposes only and by its nature addresses a hypothetical situation and, therefore, does not represent the continuing Group's actual financial position or results.
|
30 June 2025 £'m |
Sale of £'m |
Transaction fees (notes 4, 5) £'m |
Pro forma continuing Group £'m |
Non-current assets |
1.0 |
- |
- |
1.0 |
Current assets |
|
|
|
|
Trade and other receivables |
2.0 |
3.6 |
- |
5.6 |
Cash and cash equivalents |
2.1 |
9.0 |
(1.4) |
9.7 |
Assets classified as held for sale |
17.4 |
(17.4) |
- |
- |
Total assets |
22.5 |
(4.8) |
(1.4) |
16.3 |
Current liabilities |
|
|
|
|
Trade and other payables |
(4.3) |
- |
0.4 |
(3.9) |
Other current liabilities |
(1.9) |
- |
- |
(1.9) |
Liabilities classified as held for sale |
(15.4) |
15.4 |
- |
- |
Non-current liabilities |
(0.5) |
- |
- |
(0.5) |
Total liabilities |
(22.1) |
15.4 |
0.4 |
(6.3) |
Net assets |
0.4 |
10.6 |
(1.0) |
10.0 |
1. The cash movement of £9.0 million on the sale of
2. The CGT withheld is on the total transaction value of approximately £14.4 million and therefore includes tax on the deferred consideration to be paid.
3. £3.6 million trade and other receivables movement reflects Indian deferred consideration payable within 12 months.
4. The remaining transaction fees to be paid on the disposal of
5. £0.4 million trade and other payables movement reflects the transaction fees invoiced or accrued at 30 June 2025 but not paid. The payment of these is included in £1.4 million remaining transaction fees to be paid referenced in footnote 4.
Events after the balance sheet date
On 23 July 2025, the Group announced that it had agreed terms for the disposal of CPP India for total cash consideration of US$21.0 million, with US$15.8 million payable on completion and US$5.2 million payable by two equal instalments at six- and 12-months post completion, subject to certain performance targets. Consent to the disposal was passed by shareholders at a general meeting on 14 August 2025.
On 15 September 2025, the Group confirmed that it had agreed to an Amended and Restated sale and purchase agreement which revised the total consideration payable to US$20.0 million, with US$15 million payable on completion and US$ 5.0 million payable by two equal instalments at six and 12 months post completion, subject to certain revised performance targets.
The disposal completed on 17 September 2025.
Group Legacy Activities
The Group's legacy operations in the
Central Restructure
On 25 September 2025, the Group announced a reorganisation of central functions and cost reductions as it transitions to a leaner, Blink-focused organisation. The associated restructure includes a reduction in fees paid to the non-executive directors, a reduction in executive headcount, including the departure of
The various actions taken by the Group in recent years is expected to see central costs (before recharges to business units) come down from £10.1 million in 2023 to a run rate in the region of £2.5 million per year, subsequent to the most recent round of cost cutting.
People
To lead Blink through its next phase of growth,
Brian will be appointed to the board of directors of
Outlook
Blink has matured rapidly into a scalable, high-margin SaaS InsurTech platform with global reach. Our two core markets, travel disruption and cyber-security are set for continued expansion, underpinned by strong structural tailwinds.
The Group is now fully aligned behind Blink, enabling us to:
1. Deepen strategic partnerships with global insurers;
2. Accelerate commercialisation; and
3. Scale a next-generation platform designed for worldwide deployment.
With a robust partner base, strong recurring revenues, and an experienced leadership team, we are confident in Blink's long-term sustainable growth prospects and ability to deliver shareholder return.
Acknowledgement
I extend my sincere gratitude to
Chief Executive Officer
26 September 2025
CONDENSED CONSOLIDATED INTERIM FINANCIAL STATEMENTS
CONSOLIDATED INCOME STATEMENT
|
Note |
6 months ended 30 June 2025 (Unaudited) £'000 |
|
6 months ended 30 June 2024 (Restated**) (Unaudited) £'000 |
|
Year ended 31 December 2024 (Restated*) (Audited) £'000 |
Continuing operations |
|
|
|
|
|
|
Revenue |
3 |
926 |
|
1,418 |
|
2,415 |
Cost of sales |
|
(129) |
|
(278) |
|
(383) |
Gross profit |
|
797 |
|
1,140 |
|
2,032 |
Administrative expenses |
|
(4,298) |
|
(5,680) |
|
(10,377) |
Operating loss |
|
(3,501) |
|
(4,540) |
|
(8,345) |
|
|
|
|
|
|
|
Analysed as: |
|
|
|
|
|
|
EBITDA |
3 |
(2,908) |
|
(3,856) |
|
(6,608) |
Depreciation and amortisation |
|
(252) |
|
(187) |
|
(337) |
Exceptional items |
4 |
(341) |
|
(497) |
|
(1,400) |
|
|
|
|
|
|
|
Investment revenues |
|
39 |
|
138 |
|
177 |
Finance costs |
|
(51) |
|
(91) |
|
(204) |
Loss before taxation |
|
(3,513) |
|
(4,493) |
|
(8,372) |
Taxation |
5 |
- |
|
- |
|
17 |
Loss for the period from continuing operations |
|
(3,513) |
|
(4,493) |
|
(8,355) |
Discontinued operations |
|
|
|
|
|
|
Profit for the period from discontinued operations |
6 |
1,962 |
|
4,307 |
|
4,743 |
Loss for the period |
|
(1,551) |
|
(186) |
|
(3,612) |
|
|
|
|
|
|
|
Attributable to: |
|
|
|
|
|
|
Equity holders of the Company |
|
(1,551) |
|
(344) |
|
(3,590) |
Non-controlling interests |
|
- |
|
158 |
|
(22) |
|
|
(1,551) |
|
(186) |
|
(3,612) |
|
|
|
|
|
|
|
Basic & diluted (loss)/earnings per share |
|
Pence |
|
Pence |
|
Pence |
Continuing operations |
7 |
(38.33) |
|
(50.79) |
|
(92.78) |
Discontinued operations |
7 |
21.41 |
|
46.90 |
|
52.92 |
|
7 |
(16.92) |
|
(3.89) |
|
(39.86) |
* Restated to reflect
** Restated to reflect
CONSOLIDATED STATEMENT OF COMPREHENSIVE INCOME
|
|
6 months ended 30 June 2025 |
|
6 months ended 30 June 2024 |
|
Year ended 31 December 2024 |
||||||
|
|
£'000 |
|
£'000 |
|
£'000 |
||||||
|
|
(Unaudited) |
|
(Unaudited) |
|
(Audited) |
||||||
|
|
|
|
|
|
|
||||||
|
Loss for the period |
(1,551) |
|
(186) |
|
(3,612) |
||||||
|
|
|
|
|
|
|
||||||
|
Items that may be reclassified subsequently to profit or loss: |
|
|
|
|
|
||||||
|
Exchange differences on translation of foreign operations |
(585) |
|
(353) |
|
(425) |
||||||
Items that have been reclassified to profit or loss: |
|
|
|
|
|
|
||||||
|
Exchange differences reclassified on disposal of foreign operations |
2,805 |
|
(2,005) |
|
(1,626) |
||||||
|
|
|
|
|
|
|
||||||
|
Other comprehensive income/(expense) for the period net of taxation |
2,220 |
|
(2,358) |
|
(2,051) |
||||||
|
Total comprehensive income/(expense) for the period |
669 |
|
(2,544) |
|
(5,663) |
||||||
|
|
|
|
|
|
|
||||||
|
Attributable to: |
|
|
|
|
|
||||||
|
Equity holders of the Company |
669 |
|
(2,708) |
|
(5,540) |
||||||
|
Non-controlling interests |
- |
|
164 |
|
(123) |
||||||
|
|
669 |
|
(2,544) |
|
(5,663) |
||||||
|
|
|
|
|
|
|
||||||
CONSOLIDATED BALANCE SHEET
|
|
30 June 2025 |
|
30 June 2024 |
|
31 December 2024 |
|
|
£'000 |
|
£'000 |
|
£'000 |
|
Note |
(Unaudited) |
|
(Unaudited) |
|
(Audited) |
Non-current assets |
|
|
|
|
|
|
|
|
- |
|
514 |
|
- |
Other intangible assets |
|
801 |
|
6,746 |
|
6,031 |
Property, plant and equipment |
|
77 |
|
829 |
|
372 |
Right-of-use assets |
|
123 |
|
2,657 |
|
1,062 |
Deferred tax assets |
|
- |
|
707 |
|
586 |
Contract assets |
|
- |
|
201 |
|
206 |
|
|
1,001 |
|
11,654 |
|
8,257 |
Current assets |
|
|
|
|
|
|
Contract assets |
|
- |
|
6,211 |
|
5,567 |
Trade and other receivables |
|
1,976 |
|
13,060 |
|
5,422 |
Cash and cash equivalents |
|
2,107 |
|
11,636 |
|
9,650 |
|
|
4,083 |
|
30,907 |
|
20,639 |
Assets classified as held for sale |
|
17,402 |
|
- |
|
- |
|
|
21,485 |
|
30,907 |
|
20,639 |
Total assets |
3 |
22,486 |
|
42,561 |
|
28,896 |
Current liabilities |
|
|
|
|
|
|
Borrowings |
|
37 |
|
- |
|
- |
Income tax liabilities |
|
(981) |
|
(999) |
|
(1,128) |
Trade and other payables |
|
(4,348) |
|
(19,126) |
|
(14,703) |
Provisions |
8 |
(612) |
|
(1,576) |
|
(1,211) |
Lease liabilities |
|
(178) |
|
(953) |
|
(277) |
Contract liabilities |
|
(111) |
|
(10,230) |
|
(9,436) |
|
|
(6,193) |
|
(32,884) |
|
(26,755) |
Liabilities classified as held for sale |
|
(15,388) |
|
- |
|
- |
|
|
(21,581) |
|
(32,884) |
|
(26,755) |
Net current liabilities |
|
(96) |
|
(1,977) |
|
(6,116) |
Non-current liabilities |
|
|
|
|
|
|
Borrowings |
|
- |
|
86 |
|
66 |
Deferred tax liabilities |
|
- |
|
(644) |
|
(398) |
Trade and other payables |
|
(107) |
|
- |
|
- |
Provisions |
8 |
(358) |
|
(1,011) |
|
(574) |
Lease liabilities |
|
- |
|
(2,463) |
|
(751) |
Contract liabilities |
|
(14) |
|
(429) |
|
(510) |
|
|
(479) |
|
(4,461) |
|
(2,167) |
Total liabilities |
|
(22,060) |
|
(37,345) |
|
(28,922) |
Net assets |
|
426 |
|
5,216 |
|
(26) |
Equity |
|
|
|
|
|
|
Share capital |
9 |
24,574 |
|
24,257 |
|
24,574 |
Share premium account |
|
45,225 |
|
45,225 |
|
45,225 |
Merger reserve |
|
(100,399) |
|
(100,399) |
|
(100,399) |
Translation reserve |
|
(1,081) |
|
(3,715) |
|
(3,301) |
ESOP reserve |
|
18,532 |
|
18,659 |
|
18,735 |
Retained earnings |
|
13,575 |
|
18,768 |
|
15,140 |
Equity attributable to equity holders of the Company |
|
426 |
|
2,795 |
|
(26) |
Non-controlling interests |
|
- |
|
2,421 |
|
- |
Total equity |
|
426 |
|
5,216 |
|
(26) |
CONSOLIDATED STATEMENT OF CHANGES IN EQUITY
|
|
Share capital |
|
Share premium account |
|
Merger reserve |
|
Translation reserve |
|
ESOP reserve |
|
Retained earnings |
|
Total |
|
Non-controlling interests |
|
Total equity |
|
Note |
£'000 |
|
£'000 |
|
£'000 |
|
£'000 |
|
£'000 |
|
£'000 |
|
£'000 |
|
£'000 |
|
£'000 |
6 months ended 30 June 2025 (Unaudited) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
At 1 January 2025 |
|
24,574 |
|
45,225 |
|
(100,399) |
|
(3,301) |
|
18,735 |
|
15,140 |
|
(26) |
|
- |
|
(26) |
Loss for the period |
|
- |
|
- |
|
- |
|
- |
|
- |
|
(1,551) |
|
(1,551) |
|
- |
|
(1,551) |
Other comprehensive income for the period |
|
- |
|
- |
|
- |
|
2,220 |
|
- |
|
- |
|
2,220 |
|
- |
|
2,220 |
Total comprehensive income/(expense) for the period |
|
- |
|
- |
|
- |
|
2,220 |
|
- |
|
(1,551) |
|
669 |
|
- |
|
669 |
Equity-settled share-based payment credit |
|
- |
|
- |
|
- |
|
- |
|
(203) |
|
- |
|
(203) |
|
- |
|
(203) |
Effects of hyperinflation |
|
- |
|
- |
|
- |
|
- |
|
- |
|
(14) |
|
(14) |
|
- |
|
(14) |
At 30 June 2025 |
|
24,574 |
|
45,225 |
|
(100,399) |
|
(1,081) |
|
18,532 |
|
13,575 |
|
426 |
|
- |
|
426 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
6 months ended 30 June 2024 (Unaudited) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
At 1 January 2024 |
|
24,257 |
|
45,225 |
|
(100,399) |
|
(1,351) |
|
18,334 |
|
19,192 |
|
5,258 |
|
2,257 |
|
7,515 |
Loss for the period |
|
- |
|
- |
|
- |
|
- |
|
- |
|
(344) |
|
(344) |
|
158 |
|
(186) |
Other comprehensive expense for the period |
|
- |
|
- |
|
- |
|
(2,364) |
|
- |
|
- |
|
(2,364) |
|
6 |
|
(2,358) |
Total comprehensive expense for the period |
|
- |
|
- |
|
- |
|
(2,364) |
|
- |
|
(344) |
|
(2,708) |
|
164 |
|
(2,544) |
Equity-settled share-based payment charge |
|
- |
|
- |
|
- |
|
- |
|
325 |
|
- |
|
325 |
|
- |
|
325 |
Effects of hyperinflation |
|
- |
|
- |
|
- |
|
- |
|
- |
|
(80) |
|
(80) |
|
- |
|
(80) |
At 30 June 2024 |
|
24,257 |
|
45,225 |
|
(100,399) |
|
(3,715) |
|
18,659 |
|
18,768 |
|
2,795 |
|
2,421 |
|
5,216 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year ended 31 December 2024 (Audited) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
At 1 January 2024 |
|
24,257 |
|
45,225 |
|
(100,399) |
|
(1,351) |
|
18,334 |
|
19,192 |
|
5,258 |
|
2,257 |
|
7,515 |
Loss for the year |
|
- |
|
- |
|
- |
|
- |
|
- |
|
(3,590) |
|
(3,590) |
|
(22) |
|
(3,612) |
Other comprehensive expense for the year |
|
- |
|
- |
|
- |
|
(1,950) |
|
- |
|
- |
|
(1,950) |
|
(101) |
|
(2,051) |
Total comprehensive expense for the period |
|
- |
|
- |
|
- |
|
(1,950) |
|
- |
|
(3,590) |
|
(5,540) |
|
(123) |
|
(5,663) |
Disposal of non-controlling interests |
|
- |
|
- |
|
- |
|
- |
|
- |
|
- |
|
- |
|
(2,134) |
|
(2,134) |
Equity-settled share-based payment charge |
|
- |
|
- |
|
- |
|
- |
|
649 |
|
- |
|
649 |
|
- |
|
649 |
Exercise of share options |
|
317 |
|
- |
|
- |
|
- |
|
- |
|
(317) |
|
- |
|
- |
|
- |
Purchase of own shares |
|
- |
|
- |
|
- |
|
- |
|
(248) |
|
- |
|
(248) |
|
- |
|
(248) |
Effects of hyperinflation |
|
- |
|
- |
|
- |
|
- |
|
- |
|
(145) |
|
(145) |
|
- |
|
(145) |
At 31 December 2024 |
|
24,574 |
|
45,225 |
|
(100,399) |
|
(3,301) |
|
18,735 |
|
15,140 |
|
(26) |
|
- |
|
(26) |
CONSOLIDATED CASH FLOW STATEMENT
|
Note |
6 months ended 30 June 2025 |
|
6 months ended 30 June 2024 |
|
Year ended 31 December 2024 |
|
|
£'000 |
|
£'000 |
|
£'000 |
|
|
(Unaudited) |
|
(Unaudited) |
|
(Audited) |
|
|
|
|
|
|
|
Net cash used in operating activities |
10 |
(3,219) |
|
(8,641) |
|
(9,738) |
|
|
|
|
|
|
|
Investing activities |
|
|
|
|
|
|
Interest received |
|
188 |
|
494 |
|
447 |
Purchases of property, plant and equipment |
|
(33) |
|
(170) |
|
(270) |
Purchases of intangible assets |
|
(197) |
|
(1,282) |
|
(1,769) |
Sale of equity investment |
|
- |
|
2,651 |
|
2,651 |
Cash consideration in respect of sale of discontinued operations |
|
3,064 |
|
434 |
|
4,237 |
Costs associated with disposal of discontinued operations |
|
(250) |
|
(20) |
|
(92) |
Cash disposed of with discontinued operations |
|
(333) |
|
(151) |
|
(3,275) |
|
|
|
|
|
|
|
Net cash from investing activities |
|
2,439 |
|
1,956 |
|
1,929 |
|
|
|
|
|
|
|
Financing activities |
|
|
|
|
|
|
Repayment of the lease liabilities |
|
(117) |
|
(638) |
|
(966) |
Interest paid |
|
(122) |
|
(32) |
|
(77) |
Purchase of own shares |
|
- |
|
- |
|
(248) |
|
|
|
|
|
|
|
Net cash used in financing activities |
|
(239) |
|
(670) |
|
(1,291) |
Net decrease in cash and cash equivalents |
(1,019) |
|
(7,355) |
|
(9,100) |
|
|
|
|
|
|
|
|
Effect of foreign exchange rate changes |
(562) |
|
(10) |
|
(251) |
|
Cash and cash equivalents at start of period |
9,650 |
|
19,001 |
|
19,001 |
|
|
|
|
|
|
|
|
Cash and cash equivalents at end of period |
8,069 |
|
11,636 |
|
9,650 |
|
|
|
|
|
|
|
|
Analysed as: |
|
|
|
|
|
|
Continuing operations |
2,107 |
|
11,636 |
|
9,650 |
|
Discontinued operations |
5,962 |
|
- |
|
- |
|
|
|
|
|
|
|
|
|
8,069 |
|
11,636 |
|
9,650 |
NOTES TO THE CONDENSED CONSOLIDATED INTERIM FINANCIAL STATEMENTS
1 General information
The condensed consolidated interim financial statements for the six months ended 30 June 2025 do not constitute statutory accounts as defined under Section 434 of the Companies Act 2006. The Annual Report and Financial Statements (the 'Financial Statements') for the year ended 31 December 2024 were approved by the Board on 25 March 2025 and have been delivered to the Registrar of Companies. The Auditor,
2 Accounting policies
Basis of preparation
The unaudited condensed consolidated interim financial statements for the six months ended 30 June 2025 have been prepared in accordance with IAS 34 Interim Financial Reporting. They do not include all the information required for full annual financial statements and should be read in conjunction with the Group's consolidated financial statements for the year ended 31 December 2024 which were prepared in accordance with international accounting standards in conformity with the requirements of the Companies Act 2006 and
The accounting policies adopted in the preparation of the condensed consolidated interim financial statements are consistent with those followed in the preparation of the Group's consolidated financial statements for the year ended 31 December 2024, except as detailed below.
New standards
Amendments to IAS 21 is applicable for the first time in the current period. There has been no material impact to the Group on adoption.
Restatement of disclosures
On 17 June 2025, the Group completed the sale of its wholly owned subsidiary
As at 30 June 2025 negotiations were advanced for the sale of
Discontinued operations in the prior periods also contain, Globiva,
The adjustments related to the restatement for
Core and Legacy disclosures
In 2022, the Group adopted a multi-column format on the face of the Consolidated Income Statement and associated notes which split the results into Core and Legacy operations. Core and Legacy operations have now reduced following the disposal and closure of various entities, with Legacy having substantially reduced so only the
Hyperinflation
The Group had operations within
Going concern
In reaching their view on the preparation of the condensed consolidated interim financial statements on a going concern basis, the Directors are required to consider whether the Group can continue in operational existence for a period of at least 12 months from the date of this report.
The Group has a formalised process of budgeting, reporting and review along with procedures to forecast its profitability and cash flows. The plans provide information to the Directors which are used to ensure the adequacy of resources available for the Group to meet its business objectives, both in the short-term and in relation to its strategic priorities. The Group's revenue, profit and cash flow forecasts are subject to robust downside stress testing which involves modelling the impact of a combination of plausible adverse scenarios focused on crystallisation of the Group's key business risks. This is done to identify risks to liquidity and enable management to formulate appropriate and timely mitigation strategies.
Taking the analysis into consideration, the Directors are satisfied that the Group has the necessary resources to continue in operational existence for a period of at least 12 months from the date of this report. Accordingly, they continue to adopt the going concern basis in preparing the condensed consolidated interim financial statements.
3 Segmental analysis
IFRS 8 Operating Segments requires operating segments to be identified on the basis of internal reports about components of the Group that are regularly reviewed by the Board of Directors to allocate resources to the segments and to assess their performance.
The Group is managed on the basis of three broad business units:
• Blink;
• Central Functions - central cost base required to provide expertise and operate a listed group. Central Functions is stated after the recharge of certain central costs that are appropriate to transfer to the relevant geographies for statutory purposes; and
• Legacy (
In June 2025, the
Segment revenue and performance for the current and comparative periods are presented below:
|
|
|
Central Functions |
|
Legacy |
|
Total |
Six months ended 30 June 2025 (Unaudited) |
£'000 |
|
£'000 |
|
£'000 |
|
£'000 |
Continuing operations |
|
|
|
|
|
|
|
Revenue - external sales |
812 |
|
- |
|
114 |
|
926 |
Cost of sales |
(109) |
|
- |
|
(20) |
|
(129) |
Gross profit |
703 |
|
- |
|
94 |
|
797 |
Administrative expenses excluding depreciation, amortisation, and exceptional items |
(1,944) |
|
(1,667) |
|
(94) |
|
(3,705) |
EBITDA |
(1,241) |
|
(1,667) |
|
- |
|
(2,908) |
Depreciation and amortisation |
(128) |
|
(124) |
|
- |
|
(252) |
Exceptional items (note 4) |
(183) |
|
(133) |
|
(25) |
|
(341) |
Operating loss |
(1,552) |
|
(1,924) |
|
(25) |
|
(3,501) |
Investment revenues |
|
|
|
|
|
|
39 |
Finance costs |
|
|
|
|
|
|
(51) |
Loss before taxation |
|
|
|
|
|
|
(3,513) |
Taxation |
|
|
|
|
|
|
- |
Loss for the period from continuing operations |
|
|
|
|
|
|
(3,513) |
Discontinued operations |
|
|
|
|
|
|
|
Profit for the period from discontinued operations (note 6) |
|
|
|
|
|
|
1,962 |
Loss for the period |
|
|
|
|
|
|
(1,551) |
|
Blink |
|
Central Functions |
|
Legacy |
|
Total |
Six months ended 30 June 2024 (Restated*) (Unaudited) |
£'000 |
|
£'000 |
|
£'000 |
|
£'000 |
Continuing operations |
|
|
|
|
|
|
|
Revenue - external sales |
|
|
|
|
914 |
|
1,418 |
Cost of sales |
(88) |
|
- |
|
(190) |
|
(278) |
Gross profit |
416 |
|
- |
|
724 |
|
1,140 |
Administrative expenses excluding depreciation, amortisation, and exceptional items |
(1,419) |
|
(2,369) |
|
(1,208) |
|
(4,996) |
EBITDA |
(1,003) |
|
(2,369) |
|
(484) |
|
(3,856) |
Depreciation and amortisation |
(59) |
|
(127) |
|
(1) |
|
(187) |
Exceptional items (note 4) |
(44) |
|
(236) |
|
(217) |
|
(497) |
Operating loss |
(1,106) |
|
(2,732) |
|
(702) |
|
(4,540) |
Investment revenues |
|
|
|
|
|
|
138 |
Finance costs |
|
|
|
|
|
|
(91) |
Loss before taxation |
|
|
|
|
|
|
(4,493) |
Taxation |
|
|
|
|
|
|
- |
Loss for the period from continuing operations |
|
|
|
|
|
|
(4,493) |
Discontinued operations |
|
|
|
|
|
|
|
Profit for the period from discontinued operations (note 6) |
|
|
|
|
|
|
4,307 |
Loss for the period |
|
|
|
|
|
|
(186) |
* Restated to reflect
|
Blink |
|
Central Functions |
|
Legacy |
|
Total |
Year ended 31 December 2024 (Restated)* (Audited) |
£'000 |
|
£'000 |
|
£'000 |
|
£'000 |
Continuing operations |
|
|
|
|
|
|
|
Revenue - external sales |
1,065 |
|
- |
|
1,350 |
|
2,415 |
Cost of sales |
(253) |
|
- |
|
(130) |
|
(383) |
Gross profit |
812 |
|
- |
|
1,220 |
|
2,032 |
Administrative expenses excluding depreciation, amortisation, and exceptional items |
(3,517) |
|
(3,534) |
|
(1,589) |
|
(8,640) |
EBITDA |
(2,705) |
|
(3,534) |
|
(369) |
|
(6,608) |
Depreciation and amortisation |
(145) |
|
(191) |
|
(1) |
|
(337) |
Exceptional items (note 4) |
(78) |
|
(1,078) |
|
(244) |
|
(1,400) |
Operating loss |
(2,928) |
|
(4,803) |
|
(614) |
|
(8,345) |
Investment revenues |
|
|
|
|
|
|
177 |
Finance costs |
|
|
|
|
|
|
(204) |
Loss before taxation |
|
|
|
|
|
|
(8,372) |
Taxation |
|
|
|
|
|
|
17 |
Loss for the period from continuing operations |
|
|
|
|
|
|
(8,355) |
Discontinued operations |
|
|
|
|
|
|
|
Profit for the period from discontinued operations (note 6) |
|
|
|
|
|
|
4,743 |
Loss for the period |
|
|
|
|
|
|
(3,612) |
* Restated to reflect
Segmental assets
|
30 June 2025 |
|
30 June 2024 |
|
31 December 2024 |
|
£'000 |
|
£'000 |
|
£'000 |
|
(Unaudited) |
|
(Unaudited)** |
|
(Audited)* |
|
|
|
|
|
|
Blink |
1,560 |
|
928 |
|
1,247 |
Central Functions |
1,748 |
|
1,831 |
|
1,531 |
Legacy |
1,776 |
|
3,854 |
|
1,934 |
Total segment assets |
5,084 |
|
6,613 |
|
4,712 |
Unallocated assets |
- |
|
1,221 |
|
586 |
Assets relating to discontinued operations |
17,402 |
|
34,727 |
|
23,598 |
Consolidated total assets |
22,486 |
|
42,561 |
|
28,896 |
* Restated to reflect
** Restated to reflect
4 Exceptional items
|
6 months ended 30 June 2025 (Unaudited) £'000 |
|
6 months ended 30 June 2024 (Restated**) (Unaudited) £'000 |
|
Year ended 31 December 2024 (Restated*) (Audited) £'000 |
Continuing operations |
|
|
|
|
|
Restructuring and closure costs |
341 |
|
375 |
|
851 |
Onerous contracts |
- |
|
(91) |
|
(25) |
DBP charges |
- |
|
213 |
|
574 |
Exceptional charge included in operating profit |
341 |
|
497 |
|
1,400 |
Tax on exceptional items |
- |
|
- |
|
(6) |
Total exceptional charge after tax for continuing operations |
341 |
|
497 |
|
1,394 |
Discontinued operations |
|
|
|
|
|
Exceptional charge/(gain) from discontinued operations net of tax (note 6) |
69 |
|
(1,874) |
|
(642) |
Total exceptional charge/(gain) after tax |
410 |
|
(1,377) |
|
752 |
* Restated to reflect
** Restated to reflect
Restructuring and closure costs of £341,000 from continuing operations (H1 2024 restated: £375,000; year ended 31 December 2024 restated: £851,000) primarily relate to redundancy and associated costs in Blink and Central Functions, as well as necessary retention provisions as the
Prior period DBP charges - relating to an exceptional deferred bonus plan ceased in December 2024 and there has been no revision to the onerous contract provision in the current period.
5 Taxation
The current period tax charge of £nil (H1 2024 restated: £nil; year ended 31 December 2024 restated: £17,000) is reflective of the losses made in our continuing businesses. Tax relief is not yet able to be recognised against the losses. As Blink moves to profitability it is expected to be able to recognise a deferred tax asset, which will reflect historic losses or group relief available.
6 Discontinued operations
On 17 June 2025, the Group completed the sale of its 100% shareholding in
As at 30 June 2025,
Profit from discontinued operations comprises the following:
(i) Income statement
Six months ended 30 June 2025 |
|
|
|
|
|
|
|
Total |
|
(Unaudited) |
|
|
|
£'000 |
|
£'000 |
|
£'000 |
|
|
|
|
|
|
|
|
|
|
|
Revenue |
|
|
|
5,786 |
|
69,484 |
|
75,270 |
|
Cost of sales |
|
|
|
(3,578) |
|
(62,930) |
|
(66,508) |
|
Gross profit |
|
|
|
2,208 |
|
6,554 |
|
8,762 |
|
Administrative expenses |
|
|
|
(1,283) |
|
(4,776) |
|
(6,059) |
|
Operating profit |
|
|
|
925 |
|
1,778 |
|
2,703 |
|
Analysed as: EBITDA Depreciation and amortisation Exceptional items |
|
|
|
975 (145) 95 |
|
2,872 (930) (164) |
|
3,847 (1,075) (69) |
|
Investment revenues |
|
|
|
48 |
|
101 |
|
149 |
|
Finance costs |
|
|
|
(110) |
|
(3) |
|
(113) |
|
Profit before taxation |
|
|
|
863 |
|
1,876 |
|
2,739 |
|
Taxation |
|
|
|
(262) |
|
(515) |
|
(777) |
|
Profit for the period |
|
|
|
601 |
|
1,361 |
|
1,962 |
Six months ended 30 June 2024 |
|
|
|
|
Globiva |
|
|
|
|
|
Total |
(Unaudited) (restated*) |
£'000 |
|
£'000 |
|
£'000 |
|
£'000 |
|
£'000 |
|
£'000 |
|
|
|
|
|
|
|
|
|
|
|
|
Revenue |
3,210 |
|
76,401 |
|
8,114 |
|
687 |
|
53 |
|
88,465 |
Cost of sales |
(1,698) |
|
(68,684) |
|
(6,377) |
|
(308) |
|
(2) |
|
(77,069) |
Gross profit |
1,512 |
|
7,717 |
|
1,737 |
|
379 |
|
51 |
|
11,396 |
Administrative expenses |
(883) |
|
(5,168) |
|
(1,378) |
|
63 |
|
(637) |
|
(8,003) |
Operating profit/(loss) |
629 |
|
2,549 |
|
359 |
|
442 |
|
(586) |
|
3,393 |
Analysed as: EBITDA Depreciation and amortisation Exceptional items |
705 (76) - |
|
3,444 (895) - |
|
866 (507) - |
|
99 (37) 380 |
|
(131) - (455) |
|
4,983 (1,515) (75) |
Investment revenues |
222 |
|
56 |
|
109 |
|
- |
|
- |
|
387 |
Finance costs |
(15) |
|
(1) |
|
(147) |
|
(1) |
|
(2) |
|
(166) |
Other gains and losses |
- |
|
- |
|
- |
|
- |
|
1,949 |
|
1,949 |
Profit before taxation |
836 |
|
2,604 |
|
321 |
|
441 |
|
1,361 |
|
5,563 |
Taxation |
(329) |
|
(757) |
|
(170) |
|
- |
|
- |
|
(1,256) |
Profit for the period |
507 |
|
1,847 |
|
151 |
|
441 |
|
1,361 |
|
4,307 |
* Restated to reflect
Year ended 31 December 2024 |
|
|
|
|
Globiva |
|
|
|
|
|
Other |
|
Total |
(Unaudited) (restated*) |
£'000 |
|
£'000 |
|
£'000 |
|
£'000 |
|
£'000 |
|
£'000 |
|
£'000 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Revenue |
8,610 |
|
145,401 |
|
10,790 |
|
687 |
|
53 |
|
- |
|
165,541 |
Cost of sales |
(5,037) |
|
(130,198) |
|
(8,446) |
|
(309) |
|
(2) |
|
- |
|
(143,992) |
Gross profit |
3,573 |
|
15,203 |
|
2,344 |
|
378 |
|
51 |
|
- |
|
21,549 |
Administrative expenses |
(2,634) |
|
(10,596) |
|
(2,305) |
|
63 |
|
(653) |
|
- |
|
(16,125) |
Operating profit/(loss) |
939 |
|
4,607 |
|
39 |
|
441 |
|
(602) |
|
- |
|
5,424 |
Analysed as: EBITDA Depreciation and amortisation Exceptional items |
1,406 (215) (252) |
|
6,630 (1,883) (140) |
|
1,211 (661) (511) |
|
98 (37) 380 |
|
(135) - (467) |
|
- - - |
|
9,210 (2,796) (990) |
Investment revenues |
- |
|
153 |
|
117 |
|
- |
|
- |
|
- |
|
270 |
Finance costs |
(58) |
|
(15) |
|
(205) |
|
- |
|
(3) |
|
- |
|
(281) |
Other gains and losses |
- |
|
- |
|
- |
|
- |
|
1,949 |
|
33 |
|
1,982 |
Profit/(loss) before taxation |
881 |
|
4,745 |
|
(49) |
|
441 |
|
1,344 |
|
33 |
|
7,395 |
Taxation |
(195) |
|
(1,750) |
|
(674) |
|
- |
|
(33) |
|
- |
|
(2,652) |
Profit/(loss) for year |
686 |
|
2,995 |
|
(723) |
|
441 |
|
1,311 |
|
33 |
|
4,743 |
* Restated to reflect
Other discontinued operations include
(ii) Exceptional items
Six months ended 30 June 2025 |
Note |
|
|
|
|
|
|
Total |
|
(Unaudited) |
|
|
|
£'000 |
|
£'000 |
|
£'000 |
|
|
|
|
|
|
|
|
|
|
|
Profit on disposal |
6 (iii) |
|
|
95 |
|
- |
|
95 |
|
Disposal costs |
|
|
|
- |
|
(164) |
|
(164) |
|
Exceptional items included in operating profit |
|
|
|
95 |
|
(164) |
|
(69) |
|
Total exceptional items after tax |
|
|
|
95 |
|
(164) |
|
(69) |
|
|
|
|
|
|
|
|
|
|
Six months ended 30 June 2024 |
|
|
|
|
|
Total |
(Unaudited) |
|
£'000 |
|
£'000 |
|
£'000 |
Profit on disposal |
6 (iii) |
380 |
|
- |
|
380 |
Write down of assets on wind up of discontinued operation |
|
- |
|
(414) |
|
(414) |
Restructuring costs |
|
- |
|
(41) |
|
(41) |
Exceptional items included in operating profit/(loss) |
|
380 |
|
(455) |
|
(75) |
Other gains and losses |
|
- |
|
1,949 |
|
1,949 |
Total exceptional items after tax |
|
380 |
|
1,494 |
|
1,874 |
Year ended 31 December 2024 |
|
|
|
|
Globiva |
|
|
|
|
|
Other |
|
Total |
(Unaudited) (restated*) |
£'000 |
|
£'000 |
|
£'000 |
|
£'000 |
|
£'000 |
|
£'000 |
|
£'000 |
(Loss)/profit on disposal |
- |
|
- |
|
(511) |
|
380 |
|
- |
|
- |
|
(131) |
Write down of assets on wind up of discontinued operation |
- |
|
- |
|
- |
|
- |
|
(414) |
|
- |
|
(414) |
Disposal costs |
(252) |
|
(140) |
|
- |
|
- |
|
(53) |
|
- |
|
(445) |
Exceptional items included in operating (loss)/profit |
(252) |
|
(140) |
|
(511) |
|
380 |
|
(467) |
|
- |
|
(990) |
Other gains and losses |
- |
|
- |
|
- |
|
- |
|
1,949 |
|
33 |
|
1,982 |
Tax on exceptional items |
- |
|
- |
|
(350) |
|
- |
|
- |
|
- |
|
(350) |
Total exceptional items after tax |
(252) |
|
(140) |
|
(861) |
|
380 |
|
1,482 |
|
33 |
|
642 |
* Restated to reflect
(iii) Profit/(loss) on disposal
The Group has recognised a profit on the disposal of
Six months ended 30 June 2025 |
|
|
|
|
Total |
(Unaudited) |
|
|
|
|
£'000 |
|
|
|
|
|
(Unaudited) |
Cash consideration |
|
|
|
|
3,064 |
Deferred consideration |
|
|
|
|
1,355 |
Proceeds |
|
|
|
|
4,419 |
Net assets sold |
|
|
|
|
(1,219) |
Costs associated with disposal |
|
|
|
|
(300) |
Currency translation differences on disposal |
|
|
|
|
(2,805) |
Profit on disposal |
|
|
|
|
95 |
On an undiscounted basis the consideration totals £4,564,000 comprising £3,064,000 paid on completion with £1,000,000 deferred for one year and £500,000 deferred for two years. The deferred amounts have been discounted by £145,000 to a total present value of £1,355,000 resulting in the discounted proceeds total of £4,419,000.
The Group recognised a (loss)/profit on the disposal in the year ended 31 December 2024:
Year ended 31 December 2024 |
|
|
Globiva |
|
Total |
|
|
|
£'000 |
£'000 |
£'000 |
|
|
|
|
|
|
Proceeds |
|
|
3,804 |
433 |
4,237 |
Net assets |
|
|
(6,103) |
(5) |
(6,108) |
Non-controlling interest on disposal |
|
|
2,134 |
- |
2,134 |
Costs associated with disposal |
|
|
- |
(72) |
(72) |
Currency translation differences on disposal |
|
|
(346) |
24 |
(322) |
(Loss)/profit on disposal |
|
|
(511) |
380 |
(131) |
For the six months ended 30 June 2024 only the profit on the disposal of
Information about major customers
Revenue from customers of one business partner in
7 (Loss)/earnings per share
Basic and diluted (loss)/earnings per share (EPS) has been calculated in accordance with IAS 33 Earnings per share. Underlying (loss)/earnings per share has also been presented to give a better understanding of the performance of the business. In accordance with IAS 33, potential ordinary shares are only considered dilutive when their conversion would decrease the EPS or increase the loss per share attributable to equity holders.
Six months ended 30 June 2025 (Unaudited) |
Continuing operations |
Discontinued operations |
Total |
(Loss)/earnings |
£'000 |
£'000 |
£'000 |
|
|
|
|
(Loss)/earnings for the purposes of basic and diluted loss per share |
(3,513) |
1,962 |
(1,551) |
Exceptional items (net of tax) |
341 |
69 |
410 |
(Loss)/earnings for the purposes of basic and diluted underlying (loss)/earnings per share |
(3,172) |
2,031 |
(1,141) |
|
|
|
|
|
|
|
|
Number of shares |
|
|
Number |
|
|
|
(thousands) |
Weighted average number of ordinary shares for the purposes of basic (loss)/earnings per share and basic underlying (loss)/earnings per share |
|
|
9,165 |
Effect of dilutive ordinary shares: share options |
|
|
1,279 |
Weighted average number of ordinary shares for the purposes of diluted (loss)/earnings per share and diluted underlying (loss)/earnings per share |
|
|
10,444 |
|
|
|
|
|
|
|
|
(Loss)/earnings per share |
Continuing operations |
Discontinued operations |
Total |
|
pence |
pence |
pence |
|
|
|
|
Basic and diluted (loss)/earnings per share |
(38.33) |
21.41 |
(16.92) |
|
|
|
|
Basic and diluted underlying (loss)/earnings per share |
(34.61) |
22.16 |
(12.45) |
|
|
|
|
Six months ended 30 June 2024 (Restated*) (Unaudited) |
Continuing operations |
Discontinued operations |
Total |
(Loss)/earnings |
£'000 |
£'000 |
£'000 |
|
|
|
|
(Loss)/earnings for the purposes of basic and diluted (loss)/earnings per share |
(4,493) |
4,149 |
(344) |
Exceptional items (net of tax) |
497 |
(1,874) |
(1,377) |
(Loss)/earnings for the purposes of underlying basic and diluted (loss)/earnings per share |
(3,996) |
2,275 |
(1,721) |
|
|
|
|
|
|
|
|
Number of shares |
|
|
Number |
|
|
|
(thousands) |
|
|
|
|
Weighted average number of ordinary shares for the purposes of basic (loss)/earnings per share and basic underlying (loss)/earnings per share |
|
|
8,847 |
Effect of dilutive ordinary shares: share options |
|
|
1,223 |
Weighted average number of ordinary shares for the purposes of diluted (loss)/earnings per share and diluted underlying (loss)/earnings per share |
|
|
10,070 |
|
|
|
|
(Loss)/earnings per share |
Continuing operations |
Discontinued operations |
Total |
|
pence |
pence |
pence |
|
|
|
|
Basic and diluted (loss)/earnings per share |
(50.79) |
46.90 |
(3.89) |
|
|
|
|
Basic and diluted underlying (loss)/earnings per share |
(45.17) |
25.71 |
(19.46) |
|
|
|
|
* Restated to reflect
Year ended 31 December 2024 (Restated*) (Unaudited) |
Continuing operations |
Discontinued operations |
Total |
(Loss)/earnings |
£'000 |
£'000 |
£'000 |
|
|
|
|
(Loss)/earnings for the purposes of basic and diluted (loss)/earnings per share |
|
4,765 |
|
Exceptional items (net of tax) |
1,394 |
(642) |
752 |
(Loss)/earnings for the purposes of basic and diluted underlying (loss)/earnings per share |
(6,961) |
4,123 |
(2,838) |
|
|
|
|
|
|
|
|
|
|
|
|
Number of shares |
|
|
Number |
|
|
|
(thousands) |
|
|
|
|
Weighted average number of ordinary shares for the purposes of basic (loss)/earnings per share and basic underlying (loss)/earnings per share |
|
|
9,005 |
Effect of dilutive ordinary shares: share options |
|
|
1,369 |
Weighted average number of ordinary shares for the purposes of diluted (loss)/earnings per share and diluted underlying (loss)/earnings per share |
|
|
10,374 |
|
|
|
|
(Loss)/earnings per share |
Continuing operations |
Discontinued operations |
Total |
|
pence |
pence |
pence |
|
|
|
|
Basic and diluted (loss)/earnings per share |
(92.78) |
52.92 |
(39.86) |
|
|
|
|
Basic and diluted underlying (loss)/earnings per share |
(77.30) |
45.79 |
(31.51) |
|
|
|
|
* Restated to reflect
8 Provisions
|
30 June 2025 £'000 |
30 June 2024 £'000 |
31 December 2024 £'000 |
At 1 January |
1,785 |
3,465 |
3,465 |
Utilised in the period |
(902) |
(855) |
(1,679) |
Released in the period |
- |
(91) |
(145) |
Interest |
87 |
68 |
144 |
Total |
970 |
2,587 |
1,785 |
At the balance sheet date there are provisions for onerous contracts due to the closure of the Legacy business. The provisions are expected to be settled as follows:
|
30 June 2025 £'000 |
30 June 2024 £'000 |
31 December 2024 £'000 |
Within one year |
612 |
1,576 |
1,211 |
Outside of one year |
358 |
1,011 |
574 |
Total |
970 |
2,587 |
1,785 |
9 Share capital
Share capital at 30 June 2025 is £24,574,000 (30 June 2024: £24,257,000; 31 December 2024: £24,574,000).
The total number of ordinary shares in issue at 30 June 2025 is 9,164,804 of which 9,159,804 are fully paid and 5,000 are partly paid.
The CPP Employee Benefit Trust holds 149,405 shares (30 June 2024: nil; 31 December 2024: 149,405).
10 Reconciliation of operating cash flows
|
6 months ended 30 June 2025 |
|
6 months ended 30 June 2024 |
|
Year ended 31 December 2024 |
|
£'000 |
|
£'000 |
|
£'000 |
|
(Unaudited) |
|
(Unaudited) |
|
(Audited) |
|
|
|
|
|
|
Loss for the period |
(1,551) |
|
(186) |
|
(3,612) |
Adjustments for: |
|
|
|
|
|
Depreciation and amortisation |
1,327 |
|
1,672 |
|
3,133 |
Share-based payment (credit)/charge |
(188) |
|
354 |
|
709 |
Loss on disposal of property, plant and equipment |
- |
|
- |
|
54 |
(Profit)/loss on disposal of discontinued operations |
(95) |
|
(383) |
|
131 |
Other gains and losses |
- |
|
(1,959) |
|
(1,982) |
Effects of hyperinflation |
(106) |
|
(207) |
|
(70) |
Investment revenues |
(188) |
|
(494) |
|
(447) |
Finance costs |
164 |
|
225 |
|
485 |
Income tax charge |
777 |
|
1,256 |
|
2,635 |
Operating cash flows before movement in working capital |
140 |
|
278 |
|
1,036 |
Decrease/(increase) in inventories |
- |
|
5 |
|
(3) |
Decrease in contract assets |
137 |
|
259 |
|
1,044 |
(Increase)/decrease in receivables |
(123) |
|
(856) |
|
3,232 |
Decrease in payables |
(1,441) |
|
(4,881) |
|
(8,157) |
Decrease in contract liabilities |
(414) |
|
(1,018) |
|
(1,974) |
Decrease in insurance liabilities |
- |
|
(77) |
|
(62) |
Decrease in provisions |
(902) |
|
(946) |
|
(1,824) |
|
|
|
|
|
|
Cash used in operations |
(2,603) |
|
(7,236) |
|
(6,708) |
|
|
|
|
|
|
Income taxes paid |
(616) |
|
(1,405) |
|
(3,030) |
|
|
|
|
|
|
Net cash used in operating activities |
(3,219) |
|
(8,641) |
|
(9,738) |
11 Related party transactions
Transactions with related parties
There have been no related party transactions in the current period.
Remuneration of key management personnel
The remuneration of the Directors, who are the key management personnel of the Group, is set out below:
|
|
|
|
6 months ended 30 June 2025 |
|
6 months ended 30 June 2024 |
|
Year ended 31 December 2024 |
|
|
|
|
£'000 |
|
£'000 |
|
£'000 |
|
|
|
|
(Unaudited) |
|
(Unaudited) |
|
(Audited) |
|
|
|
|
|
|
|
|
|
Short-term employee benefits |
653 |
|
613 |
|
1,275 |
|||
Post-employment benefits |
|
|
|
|
22 |
|||
Share-based payments |
(179) |
|
|
|
399 |
|||
|
|
|
|
|
|
|
|
|
|
|
|
|
488 |
|
800 |
|
1,696 |
|
|
|
|
|
|
|
|
|
12 Events after the balance sheet date
On 23 July 2025, the Group announced that it had agreed terms for the disposal of CPP India for total cash consideration of US$21.0 million, with US$15.8 million payable on completion and US$5.2 million payable by two equal instalments at six- and 12-months post completion, subject to certain performance targets. Consent to the disposal was passed by shareholders at a general meeting on 14 August 2025.
On 15 September 2025, the Group confirmed that it had agreed to an Amended and Restated sale and purchase agreement which revised the total consideration payable to US$20.0 million, with US$15 million payable on completion and US$ 5.0 million payable by two equal instalments at six and 12 months post completion, subject to certain revised performance targets. The disposal completed on 17 September 2025.
On 25 September 2025, the Group announced a reorganisation of central functions and cost reductions. The changes include Simon Pyper stepping down as Group CEO and assuming a new role of CFO & Managing Director of Legacy Operations, alongside the planned departures of David Bowling (CFO) and Eleanor Sykes (COO). These steps, along with other reductions in Board costs and closure of the Leeds Office are designed to align costs with the Group's new size and focus following the disposals of CPP Turkey and CPP India.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.